2m 2m 2m 2m 2m 2m 2m
ACHIEVE LIFE SCI (ACHV)
NASDAQ
$4.88-$0.04 (-0.73%)
Price as of Jun 03, 2026 7:39 PM EDT- $537.9MMarket Cap
- 19.48%1-Year Change
- BiotechnologyIndustry
ACHIEVE LIFE SCI (ACHV)
$4.88-$0.04 (-0.73%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | 34,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | -34,000 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -23.0M +0.64% | -22.8M +44.28% | -15.8M -47.42% | -30.1M +25.50% | |
Depreciation and Amortization Expense | 228,000 -0.44% | 229,000 +0.44% | 228,000 -3.39% | 236,000 +774.07% | |
Total Operating Expenses | 54.9M +40.47% | 39.1M +43.37% | 27.3M -33.21% | 40.8M +23.29% | |
Operating Profit | -54.6M +37.21% | -39.8M +33.58% | -29.8M -29.60% | -42.4M +27.74% | |
Interest Income | 1.5M -36.54% | 2.4M +185.58% | 825,000 +314.57% | 199,000 +1,070.59% | |
Interest Expense | N/A N/A | N/A N/A | -2.9M +59.47% | -1.8M N/A | |
Interest Income and Expense and Net | 1.5M -36.54% | 2.4M +216.17% | -2.0M +27.55% | -1.6M -9,452.94% | |
Total Nonoperating Income and Expense | 232,000 +130.61% | -758,000 -70.45% | -2.6M +65.48% | -1.6M +2,572.41% | |
Income before Taxes | -54.6M +37.21% | -39.8M +33.58% | -29.8M -29.60% | -42.4M +27.74% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -54.6M +37.21% | -39.8M +33.58% | -29.8M -29.60% | -42.4M +27.74% | |
Net Income from Continuing Operations Applicable to Common | -54.6M +37.21% | -39.8M +33.58% | -29.8M -29.60% | -42.4M +27.74% | |
Basic EPS and Net Income | -1.25 +0.81% | -1.24 -17.33% | -1.50 -62.50% | -4.00 -1.96% | |
Diluted EPS and Net Income | -1.25 +0.81% | -1.24 -17.33% | -1.50 -62.50% | -4.00 -1.96% | |
Basic Weighted Average Shares | 43.6M +35.93% | 32.1M +61.75% | 19.8M +87.17% | 10.6M +30.46% | |
Diluted Weighted Average Shares | 43.6M +35.93% | 32.1M +61.75% | 19.8M +87.17% | 10.6M +30.46% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 20.9M +64.11% | 12.8M -17.97% | 15.5M -37.24% | 24.8M -42.42% | |
Short-Term Investments | 15.5M -28.38% | 21.6M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 36.4M +5.95% | 34.4M +121.02% | 15.5M -37.24% | 24.8M -42.42% | |
Total Current Assets | 39.9M +9.38% | 36.5M +114.74% | 17.0M -37.86% | 27.3M -38.71% | |
Accumulated Depreciation | 111,000 -55.24% | 248,000 +2.06% | 243,000 -18.73% | 299,000 +4.18% | |
Property and Plant and Equipment and Net | 3,000 -62.50% | 8,000 -38.46% | 13,000 +225.00% | 4,000 -73.33% | |
Total Long-Term Assets | 2.0M -0.25% | 2.0M -0.25% | 2.0M +50,225.00% | 4,000 -73.33% | |
Total Assets | 41.8M +8.17% | 38.6M +99.44% | 19.4M -35.37% | 30.0M -36.92% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 3.7M -77.77% | 16.7M 0.00% | 16.7M +3.68% | 16.1M N/A | |
Total Current Liabilities | 9.1M +35.92% | 6.7M -67.90% | 20.8M -3.64% | 21.6M +374.70% | |
Total Long-Term Debt | 11.2M +13.70% | 9.8M -40.96% | 16.7M +11.68% | 14.9M 0.00% | |
Total Long-Term Liabilities | 5,000 -92.42% | 66,000 +1,000.00% | 6,000 -91.30% | 69,000 +1,625.00% | |
Total Liabilities | 20.3M +14.31% | 17.7M -14.82% | 20.8M -3.92% | 21.7M +11.27% | |
Retained Earnings | -260.2M +26.58% | -205.6M +24.03% | -165.8M +21.93% | -135.9M +45.25% | |
Total Stockholders Equity | 21.5M +2.96% | 20.9M +1,543.30% | -1.4M -117.44% | 8.3M -70.39% | |
Total Shares Outstanding | 53.2M +53.48% | 34.7M +63.87% | 21.2M +18.26% | 17.9M +89.32% | |
Cash Flow | |||||
Cash from Operating Activities | -49.5M +66.16% | -29.8M +21.61% | -24.5M -34.81% | -37.5M +27.54% | |
Capital Expenditures | 3,000 -85.71% | 21,000 0.00% | 21,000 +23.53% | 17,000 0.00% | |
Cash from Investing Activities | 6.1M +128.32% | -21.6M +102,661.90% | -21,000 +23.53% | -17,000 0.00% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 51.5M +6.18% | 48.5M +217.63% | 15.3M -20.82% | 19.3M -47.30% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -135.90% -1.04% | -137.32% +13.63% | -120.85% +10.56% | -109.31% +44.77% | |
Return on Equity | -257.67% -37.08% | -409.51% -52.92% | -869.88% +273.27% | -233.04% +129.61% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 4.39 -19.52% | 5.46 +568.89% | 0.82 -35.52% | 1.27 -87.09% | |
Cash Ratio | 2.30 +20.74% | 1.91 +155.54% | 0.75 -34.88% | 1.15 -87.87% | |
Debt-to-Equity Ratio | 0.69 -45.43% | 1.27 +105.51% | -23.01 -716.58% | 3.73 N/A | |
Debt-to-Assets Ratio | 0.36 -48.05% | 0.69 -60.13% | 1.72 +66.37% | 1.03 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow